Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells

Cheryl L. Wellington, Roshni Singaraja, Lisa Ellerby, Jane Savill, Sophie Roy, Blair Leavitt, Elena Cattaneo, Abigail S Hackam, Alan Sharp, Nancy Thornberry, Donald W. Nicholson, Dale E. Bredesen, Michael R. Hayden

Research output: Contribution to journalArticle

275 Citations (Scopus)

Abstract

Huntington's disease is a neurodegenerative disorder caused by CAG expansion that results in expansion of a polyglutamine tract at the extreme N terminus of huntingtin (htt). htt with polyglutamine expansion is proapoptotic in different cell types. Here, we show that caspase inhibitors diminish the toxicity of htt. Additionally, we define htt itself as an important caspase substrate by generating a site-directed htt mutant that is resistant to caspase-3 cleavage at positions 513 and 530 and to caspase-6 cleavage at position 586. In contrast to clearable htt, caspase-resistant htt with an expanded polyglutamine tract has reduced toxicity in apoptotically stressed neuronal and nonneuronal cells and forms aggregates at a much reduced frequency. These results suggest that inhibiting caspase cleavage of htt may therefore be of potential therapeutic benefit in Huntington's disease.

Original languageEnglish
Pages (from-to)19831-19838
Number of pages8
JournalJournal of Biological Chemistry
Volume275
Issue number26
DOIs
StatePublished - Jun 30 2000
Externally publishedYes

Fingerprint

Caspases
Toxicity
Huntington Disease
Caspase 6
Caspase Inhibitors
Caspase 3
Neurodegenerative Diseases
Substrates
polyglutamine
Therapeutics

ASJC Scopus subject areas

  • Biochemistry

Cite this

Wellington, C. L., Singaraja, R., Ellerby, L., Savill, J., Roy, S., Leavitt, B., ... Hayden, M. R. (2000). Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. Journal of Biological Chemistry, 275(26), 19831-19838. https://doi.org/10.1074/jbc.M001475200

Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. / Wellington, Cheryl L.; Singaraja, Roshni; Ellerby, Lisa; Savill, Jane; Roy, Sophie; Leavitt, Blair; Cattaneo, Elena; Hackam, Abigail S; Sharp, Alan; Thornberry, Nancy; Nicholson, Donald W.; Bredesen, Dale E.; Hayden, Michael R.

In: Journal of Biological Chemistry, Vol. 275, No. 26, 30.06.2000, p. 19831-19838.

Research output: Contribution to journalArticle

Wellington, CL, Singaraja, R, Ellerby, L, Savill, J, Roy, S, Leavitt, B, Cattaneo, E, Hackam, AS, Sharp, A, Thornberry, N, Nicholson, DW, Bredesen, DE & Hayden, MR 2000, 'Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells', Journal of Biological Chemistry, vol. 275, no. 26, pp. 19831-19838. https://doi.org/10.1074/jbc.M001475200
Wellington, Cheryl L. ; Singaraja, Roshni ; Ellerby, Lisa ; Savill, Jane ; Roy, Sophie ; Leavitt, Blair ; Cattaneo, Elena ; Hackam, Abigail S ; Sharp, Alan ; Thornberry, Nancy ; Nicholson, Donald W. ; Bredesen, Dale E. ; Hayden, Michael R. / Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. In: Journal of Biological Chemistry. 2000 ; Vol. 275, No. 26. pp. 19831-19838.
@article{7a6b7adc724f48c4b72fe12562003b39,
title = "Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells",
abstract = "Huntington's disease is a neurodegenerative disorder caused by CAG expansion that results in expansion of a polyglutamine tract at the extreme N terminus of huntingtin (htt). htt with polyglutamine expansion is proapoptotic in different cell types. Here, we show that caspase inhibitors diminish the toxicity of htt. Additionally, we define htt itself as an important caspase substrate by generating a site-directed htt mutant that is resistant to caspase-3 cleavage at positions 513 and 530 and to caspase-6 cleavage at position 586. In contrast to clearable htt, caspase-resistant htt with an expanded polyglutamine tract has reduced toxicity in apoptotically stressed neuronal and nonneuronal cells and forms aggregates at a much reduced frequency. These results suggest that inhibiting caspase cleavage of htt may therefore be of potential therapeutic benefit in Huntington's disease.",
author = "Wellington, {Cheryl L.} and Roshni Singaraja and Lisa Ellerby and Jane Savill and Sophie Roy and Blair Leavitt and Elena Cattaneo and Hackam, {Abigail S} and Alan Sharp and Nancy Thornberry and Nicholson, {Donald W.} and Bredesen, {Dale E.} and Hayden, {Michael R.}",
year = "2000",
month = "6",
day = "30",
doi = "10.1074/jbc.M001475200",
language = "English",
volume = "275",
pages = "19831--19838",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "26",

}

TY - JOUR

T1 - Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells

AU - Wellington, Cheryl L.

AU - Singaraja, Roshni

AU - Ellerby, Lisa

AU - Savill, Jane

AU - Roy, Sophie

AU - Leavitt, Blair

AU - Cattaneo, Elena

AU - Hackam, Abigail S

AU - Sharp, Alan

AU - Thornberry, Nancy

AU - Nicholson, Donald W.

AU - Bredesen, Dale E.

AU - Hayden, Michael R.

PY - 2000/6/30

Y1 - 2000/6/30

N2 - Huntington's disease is a neurodegenerative disorder caused by CAG expansion that results in expansion of a polyglutamine tract at the extreme N terminus of huntingtin (htt). htt with polyglutamine expansion is proapoptotic in different cell types. Here, we show that caspase inhibitors diminish the toxicity of htt. Additionally, we define htt itself as an important caspase substrate by generating a site-directed htt mutant that is resistant to caspase-3 cleavage at positions 513 and 530 and to caspase-6 cleavage at position 586. In contrast to clearable htt, caspase-resistant htt with an expanded polyglutamine tract has reduced toxicity in apoptotically stressed neuronal and nonneuronal cells and forms aggregates at a much reduced frequency. These results suggest that inhibiting caspase cleavage of htt may therefore be of potential therapeutic benefit in Huntington's disease.

AB - Huntington's disease is a neurodegenerative disorder caused by CAG expansion that results in expansion of a polyglutamine tract at the extreme N terminus of huntingtin (htt). htt with polyglutamine expansion is proapoptotic in different cell types. Here, we show that caspase inhibitors diminish the toxicity of htt. Additionally, we define htt itself as an important caspase substrate by generating a site-directed htt mutant that is resistant to caspase-3 cleavage at positions 513 and 530 and to caspase-6 cleavage at position 586. In contrast to clearable htt, caspase-resistant htt with an expanded polyglutamine tract has reduced toxicity in apoptotically stressed neuronal and nonneuronal cells and forms aggregates at a much reduced frequency. These results suggest that inhibiting caspase cleavage of htt may therefore be of potential therapeutic benefit in Huntington's disease.

UR - http://www.scopus.com/inward/record.url?scp=0034733607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034733607&partnerID=8YFLogxK

U2 - 10.1074/jbc.M001475200

DO - 10.1074/jbc.M001475200

M3 - Article

C2 - 10770929

AN - SCOPUS:0034733607

VL - 275

SP - 19831

EP - 19838

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 26

ER -